Doctors specialising in menopause have expressed relief following Pharmac's recent u-turn. 

Pharmac has announced it'll fund both the Estradot and Mylan brands of hormone replacement patches from December, after public consultation.

It follows backlash in response to its decision to switch suppliers 

Menodoctor Clinical Director Dr Linda Dear says this is the news they needed to hear. 

She says it's good to have these options because one may work better for some women than the other - and added losing Estradot recently was devastating.

LISTEN ABOVE

• Pharmac makes funding U-turn over patches for menopause treatment